| CMPXCompass Therapeutics, Inc. | 1,465,867 | $7.8M |
| STOKStoke Therapeutics, Inc. | 210,000 | $6.8M |
| NTLAIntellia Therapeutics, Inc. | 445,400 | $5.7M |
| GPCRStructure Therapeutics Inc. | 100,000 | $4.8M |
| SLDBSolid Biosciences Inc. | 625,980 | $4.5M |
| PRTAPROTHENA CORP PUBLIC LTD CO | 449,019 | $4.4M |
| ACADACADIA PHARMACEUTICALS INC | 171,000 | $3.8M |
| PTGXProtagonist Therapeutics, Inc | 35,000 | $3.7M |
| OLMAOlema Pharmaceuticals, Inc. | 219,000 | $3.3M |
| RLMDRELMADA THERAPEUTICS, INC. | 409,387 | $2.8M |
| OCULOCULAR THERAPEUTIX, INC | 320,000 | $2.7M |
| NKTRNEKTAR THERAPEUTICS | 31,000 | $2.2M |
| CLDXCelldex Therapeutics, Inc. | 70,095 | $2.2M |
| BCYCBICYCLE THERAPEUTICS PLC | 463,599 | $2.2M |
| CMPSCOMPASS Pathways plc | 375,000 | $2.1M |
| CYTKCYTOKINETICS INC | 30,000 | $2.0M |
| QUREuniQure N.V. | 100,697 | $1.6M |
| ZBIOZenas BioPharma, Inc. | 70,000 | $1.4M |
| KALVKalVista Pharmaceuticals, Inc. | 57,000 | $1.1M |
| AXSMAxsome Therapeutics, Inc. | 6,000 | $1.0M |
| LPCNLipocine Inc. | 111,786 | $893K |
| TVTXTravere Therapeutics, Inc. | 29,200 | $868K |
| HROWHARROW, INC. | 24,000 | $846K |
| PHVSPharvaris N.V. | 29,847 | $843K |
| APGEApogee Therapeutics, Inc. | 9,000 | $758K |
| BBIOBridgeBio Pharma, Inc. | 8,688 | $645K |
| APLSApellis Pharmaceuticals, Inc. | 14,000 | $563K |
| RCUSArcus Biosciences, Inc. | 25,889 | $559K |
| RGNXREGENXBIO Inc. | 66,270 | $555K |
| RCKTRocket Pharmaceuticals Inc. | 127,025 | $455K |
| VRDNViridian Therapeutics, Inc.\DE | 20,100 | $393K |
| CADLCandel Therapeutics, Inc. | 60,000 | $294K |
| VYGRVoyager Therapeutics, Inc. | 74,918 | $289K |
| CGEMCullinan Therapeutics, Inc. | 20,000 | $284K |
| GRCEGrace Therapeutics, Inc. | 50,000 | $232K |
| ELUTELUTIA INC. | 165,094 | $173K |
| KYNBKYNTRA BIO INC. | 22,566 | $153K |
| QNRXQuoin Pharmaceuticals, Ltd. | 20,000 | $132K |
| ZNTLZentalis Pharmaceuticals, Inc. | 17,503 | $41K |